Rapport Therapeutics, Inc. (Nasdaq: RAPP) ("Rapport” or the "Company”), a clinical-stage biotechnology company dedicated to ...

Feb. 19, 2025 — New research focuses on diagnostic delays experienced by people with epilepsy, a neurological disorder characterized by unpredictable seizures that affects over 3 million people ...

Jessica Clark, DNP, RN, Dean of the College of Nursing at Creighton University. The discussion explored the latest advancements in epilepsy treatment and NeuroOne’s breakthrough OneRF ® Ablation ...

Today's Marketplace (TMP) is proud to announce a featured interview with NeuroOne Medical Technologies Corporation (NASDAQ: ...

Cantor Fitzgerald tells investors in a research note that NeuroPace (NPCE) remains the firm’s best idea for 2025 and represents an attractive ...

When you hear the word epilepsy, what comes to mind? For many, it rsquo;s a vague image of someone having a seizure ndash; ...

RN reviews safety, expectations ... Buchhalter, PhD MD, is the former director of the pediatric epilepsy program in the Mayo Clinic Department of Neurology, Rochester, MN.

EpiScalp uses brain network analysis to diagnose epilepsy with heightened accuracy. Epilepsy is a disorder characterized by disturbances in neuronal activity resulting in seizures. One in 26 people ...

Purple Day for Epilepsy Awareness Shines Light on Local Advocate’s Journey Due to abnormal electrical activity in the brain, seizures temporarily affect the way the brain functions. March 11, 2025 ...

10th Mar 2025 7:00 am RNS Transaction in Own Shares 7th Mar 2025 7:00 am RNS Transaction in Own Shares 6th Mar 2025 7:00 am RNS Transaction in Own Shares 5th Mar 2025 7:00 am RNS Transaction in ...

After experiencing seizures every other week, Christine Kauzen has been seizure-free for months since receiving a rare ...

"We have several ongoing clinical programs examining the RNS System in expanded patient populations and new indications in epilepsy that are expected to announce data or have regulatory events in 2025 ...